Condition
Nephrolithiasis, Calcium Oxalate
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 1 (2)
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06989320Not ApplicableRecruiting
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
NCT06331546Not ApplicableRecruiting
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
NCT06330246Not ApplicableRecruiting
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
NCT02096965Phase 1CompletedPrimary
Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study
NCT00381849Phase 1Completed
Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones
Showing all 5 trials